Schonfeld Strategic Advisors LLC Sesen Bio, Inc. Transaction History

Schonfeld Strategic Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $9,198 - $16,128	-12,600 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$0.77 - $4.91 $2.94 Million - $18.7 Million	-3,815,600 Reduced 99.67%	12,600 $10,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $1.03 Million - $2.21 Million	474,110 Added 14.14%	3,828,200 $17.7 Million
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $3.91 Million - $9.74 Million	3,004,914 Added 860.57%	3,354,090 $8.72 Million
Q4 2020 Feb 16, 2021	SELL	$1.01 - $1.77 $59,210 - $103,764	-58,624 Reduced 14.38%	349,176 $471,000
Q3 2020 Nov 16, 2020	BUY	$0.67 - $1.4 $273,226 - $570,920	407,800 New	407,800 $1,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.51 $1.31 Million - $1.9 Million	-1,255,700 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.95 - $2.46 $1.19 Million - $3.09 Million	1,255,700 New	1,255,700 $1.88 Million
Q1 2019 May 15, 2019	SELL	$0.69 - $1.47 $655,744 - $1.4 Million	-950,354 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.96 - $2.04 $165,363 - $351,398	172,254 Added 22.14%	950,354 $1.35 Million
Q3 2018 Nov 14, 2018	BUY	$1.54 - $2.38 $1.2 Million - $1.85 Million	778,100 New	778,100 $1.67 Million

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.